This inventor holds 2 USPTO granted patents. Top assignee: Imperial Cancer Research Technology, Ltd.. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Penella Woll: Innovator in Cancer Research
Introduction
Penella Woll is a prominent inventor based in London, GB. She has made significant contributions to the field of cancer research, particularly through her innovative work on growth factor receptors and neuropeptide antagonists. With a total of 2 patents, her research has the potential to influence medical treatments for various conditions.
Latest Patents
Woll's latest patents include groundbreaking discoveries in the realm of growth factor receptors. One of her notable inventions is a 75-85 Kd glycopolypeptide that acts as a receptor for bombesin-type polypeptides, isolated from the surface of Swiss 3T3 cells. This invention describes certain antagonists and antibodies to the glycopolypeptide, which are structurally different from bombesin. These antagonists and antibodies are medically significant as they can influence cell proliferation stimulated by bombesin-like polypeptides. Additionally, she has developed oligopeptides that act as antagonists to cell proliferation stimulated by various neuropeptides, including vasopressin and bradykinin. These oligopeptides block a broad family of mitogenic neuropeptides that utilize the inositol signaling pathway, with implications for small cell lung cancer treatment.
Career Highlights
Woll is associated with Imperial Cancer Research Technology, Ltd., where she continues her impactful research. Her work has garnered attention for its potential applications in cancer therapies and understanding cell proliferation mechanisms.
Collaborations
Throughout her career, Woll has collaborated with esteemed colleagues such as Enrique Rozengurt and Ian Zachary. These collaborations have further enriched her research and contributed to advancements in the field.
Conclusion
Penella Woll's innovative work in cancer research exemplifies the critical role of inventors in advancing medical science. Her patents and collaborations highlight her commitment to developing effective treatments for serious health conditions.